Amoy Diagnostics accelerates global oncology research with G-P EOR™

The challenge: bringing innovative diagnostics to new markets

AmoyDx had established a strong position in China for its molecular diagnostic products. After receiving approvals for companion diagnostic kits in Japan and South Korea, the company looked to expand its oncology research and diagnostic services internationally.

This expansion introduced several challenges, including:

• Understanding local employment and compliance requirements across multiple APAC markets
• Building global teams without establishing local entities
• Ensuring new hires could quickly contribute while fully understanding AmoyDx’s mission in advancing cancer care

The solution: partnering with G-P to serve patients worldwide

To deliver its diagnostic solutions to more patients worldwide, AmoyDx needed a partner that could simplify international hiring, onboarding, and compliance. G-P’s EOR solution provided exactly that, enabling AmoyDx to hire skilled professionals in multiple countries quickly and efficiently.

G-P helped AmoyDx navigate complex employment regulations in each market while offering guidance on cultural nuances to ensure new hires felt supported and aligned with the company’s mission. From onboarding to payroll, benefits, taxes, and compliance, G-P oversaw the entire employee lifecycle, allowing AmoyDx to focus on scientific innovation and patient impact.

“The full range of global growth services from G-P helped us gain a deeper understanding of overseas talent and realize the vast opportunities in other markets, which led us to expand our presence outside of China," explained Kimi Hao, Human Resources and Admin Manager at AmoyDx. "G-P’s professionalism and commitment to compliance allowed us to expand into these new markets quickly and compliantly.”

By combining strategic guidance with operational support, G-P enabled AmoyDx to build a robust international team that could hit the ground running—often onboarding new hires in just days rather than weeks.

The impact: expanding access to cancer diagnostics worldwide

With G-P EOR, AmoyDx rapidly expanded its oncology teams and entered new markets, achieving measurable business and operational impact:

• RMB 100M (~USD 13.8M) generated by professionals outside China as of FY2022
• Onboarding time reduced dramatically, enabling new hires to contribute faster
• Streamlined management of payroll, benefits, taxes, and compliance
• Greater focus on delivering innovative diagnostic solutions and supporting clinical trials

With G-P managing employment contracts and compliance, AmoyDx reduced administrative burden and mitigated risk associated with entering new markets.

“G-P has been instrumental in allowing us to get through the employment contract stage quickly, while making sure we adhere to local employment laws in the new markets we are entering,” Hao noted.

Providing a strong employee experience remained a priority as the company scaled globally. G-P’s onboarding process ensured that new team members understood AmoyDx’s mission, core values, and role in the broader scientific and medical community.

“G-P has the highest level of professionalism and ethos,” added Hao. “The regional expertise that G-P brings helps us navigate cultural nuances and build strong global teams. Having G-P oversee the entire cycle of hiring, onboarding, compensation, benefits, taxes, and more, allows us to focus on our core business objectives.”